Abstract:Background: Bladder cancer is one of the most common malignancies in urologic system. The glucocorticoid-inducible kinase 2 (SGK2) expression and function were largely unknown in cancers. Current study was aimed to investigate the role of SGK2 in bladder cancer and its potential mechanisms. Methods: SGK2 expression was quantified by western blot (WB) in multiple bladder cancer cell lines (T24, 5637, J82 and UMUC3) compared with normal urothelial cell line (SVHUC). SGK2 knocking down and overexpression model were established by lentivirus transfection. MTT, colony formation, wound healing and transwell assay were used to assess the tumor cell proliferation, migration and invasion abilities, respectively. In addition, molecular function analysis was performed using FunRich software V3. Immunoprecipitation (IP) assay was applied to investigate the interaction between SGK2 and β-catenin at protein level. TCGA database was retrieved to verify the association between these genes and clinical tumor stage as well as prognosis among bladder cancer patients. Results: SGK2 expression was significantly upregulated in multiple bladder cancer cell lines compared with SVHUC at protein level. Cell proliferation, migration and invasion abilities were significantly decreased after knocking down SGK2 in J82 and UMUC3 cell lines. Inversely, cell aggressive phenotypes were significantly increased after overexpressing SGK2 in T24 cell line. Furthermore, functional analyses of SGK2 based on TCGA database showed that SGK2 related genes were involved in receptor activity, ATP binding, DNA repair protein, trans-membrane receptor activity and lipid binding. In addition, protein interaction analysis identified c-Myc was significantly enriched in SGK2 positively associated genes. The prediction was validated by WB and IP assay that SGK2 could directly bind with β-catenin at protein level to regulate their downstream gene c-Myc expression in bladder cancer to influence tumor progression. And clinical data generated from TCGA database also identified these downstream genes were significantly associated with tumor stage and survival status of bladder cancer patients. Conclusion: Taken together, our findings suggest SGK2 promotes bladder cancer progression via mediating β-catenin/c-Myc signaling pathway, which may serve as a potential therapeutic target for bladder cancer patients.

GSG2 promotes thyroid cancer via stabilizing AURKB and activating AKT pathway

SGSM2 Inhibits Thyroid Cancer Progression by Activating RAP1 and Enhancing Competitive RAS Inhibition.

SGK2 Promotes Renal Cancer Progression Via Enhancing ERK 1/2 and AKT Phosphorylation.

GSG2 Promotes Development and Predicts Poor Prognosis of Ovarian Cancer

Knockdown of GSG2 inhibits the development and progression of non-small cell lung cancer in vitro and in vivo .

Glucocorticoid-Inducible Kinase 2 Promotes Bladder Cancer Cell Proliferation, Migration and Invasion by Enhancing Β-Catenin/c-myc Signaling Pathway.

SGK1 in Human Cancer: Emerging Roles and Mechanisms

Sphingosine Kinase 1 Is Overexpressed And Promotes Proliferation In Human Thyroid Cancer

Effects and Mechanisms of GSG2 in Esophageal Cancer Progression.

SIK2 represses AKT/GSK3β/β‐catenin signaling and suppresses gastric cancer by inhibiting autophagic degradation of protein phosphatases

Knockdown of GATAD2A Suppresses Cell Proliferation in Thyroid Cancer in Vitro

Knockdown of GSG2 Inhibits Prostate Cancer Progressionin Vitroandin Vivo

Cmar_a_274807 499..508

CSN5 Promotes Carcinogenesis of Thyroid Carcinoma Cells Through ANGPTL2

COL4A2 enhances thyroid cancer cell proliferation through the AKT pathway

[TSR2 overexpression inhibits proliferation and invasion of gastric cancer cells by downregulating the PI3K/AKT signaling pathway]

SKP2 Contributes to AKT Activation by Ubiquitination Degradation of PHLPP1, Impedes Autophagy, and Facilitates the Survival of Thyroid Carcinoma.

Immunohistochemical basigin expression level in thyroid cancer tissues

AKT inhibits the phosphorylation level of H2A at Tyr57 via CK2 to promote the progression of gastric cancer

Interference with KCNJ2 inhibits proliferation, migration and EMT progression of apillary thyroid carcinoma cells by upregulating GNG2 expression

Cancer Stem Cell-Like Cells-Derived Exosomal CDKN2B-AS1 Stabilizes CDKN2B to Promote the Growth and Metastasis of Thyroid Cancer Via TGF-β1/Smad2/3 Signaling.